LAT1 and CD98hc scores in all cases and various category
| Subtype | LAT1 score | CD98hc score | |||||||||||||||
| N | 0 | 1 | 2 | 3 | 4 | 6 | 9 | Median (IQR) | 0 | 1 | 2 | 3 | 4 | 6 | 9 | Median (IQR) | |
| All cases | 280 | 54 | 21 | 20 | 52 | 5 | 47 | 81 | 3 (1–9) | 23 | 30 | 17 | 63 | 13 | 56 | 78 | 4 (2.8–9) |
| TNBC | 78 | 2 | 3 | 0 | 8 | 2 | 15 | 48 | 9 (6–9)* | 3 | 4 | 2 | 6 | 6 | 15 | 42 | 9 (4–9)* |
| NTNBC | 202 | 52 | 18 | 20 | 44 | 3 | 32 | 33 | 3 (0–6)* | 20 | 26 | 15 | 57 | 7 | 41 | 36 | 3 (2–6)* |
| Luminal A | 151 | 45 | 17 | 18 | 33 | 3 | 20 | 15 | 2 (0–3.5) | 17 | 24 | 12 | 50 | 7 | 25 | 16 | 3 (1–6) |
| Luminal B | 17 | 3 | 0 | 2 | 5 | 0 | 4 | 3 | 3 (2–6) | 1 | 1 | 2 | 3 | 0 | 4 | 6 | 6 (3–9) |
| HER2 | 34 | 4 | 1 | 0 | 6 | 0 | 8 | 15 | 6 (3–9) | 2 | 1 | 1 | 4 | 0 | 12 | 14 | 6 (6–9) |
*P value <0.0001.
HER2, human epidermal growth factor receptor-2; LAT1, L-type amino acid transporter1; NTNBC, non-triple-negative breast cancer; TNBC, triple-negative breast cancer.